semaglutide types GLP-1 for Medical Weight Loss Semaglutide for the Treatment of

Human clinical evidence is limited

For patients with higher-risk factorssuch as significant gastrointestinal symptoms or known delayed gastric emptying simple precautions can reduce the risk

However, their potential implications for colorectal cancer highlight the need for cautious use and further research

It is important to continue to be mindful of proper nutrition while using medications such as GLP-1 & GIP therapy to help lose fat and maintain lean muscle mass, which is vital for your overall metabolic health

doi: 10.1124/jpet.114.218735

RESEARCH HIGHLIGHT In the phase 3 EVOKE(+) trials, semaglutide did not slow clinical progression of Alzheimers disease, but the findings provide new insights in the ongoing quest for treatments